COMMUNIQUÉS West-GlobeNewswire

ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
04/05/2026
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026 Reported rinzimetostat data in [...]
Option Care Health to Participate in the Bank of America Health Care Conference
04/05/2026
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
04/05/2026
RESEARCH TRIANGLE PARK, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Teva to Present at the BofA Securities Health Care Conference
04/05/2026
PARSIPPANY, N.J., and TEL AVIV, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Eric Hughes, Teva's EVP of Global R&D & Chief Medical [...]
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
04/05/2026
$55 million funded at closing to repay existing loan facility THE WOODLANDS, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has entered into a loan facility [...]
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
04/05/2026
MELBOURNE, Australia and INDIANAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the publication of a new independent analysis of Phase 3 ZIRCON [...]
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
04/05/2026
Clinical development strategy includes an mCRPC-dedicated Phase 1b trial in PLUVICTO®-naïve and -experienced patients, and a second Phase 1b basket trial in other B7-H3 expressing solid tumors Two-trial strategy enables [...]
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
04/05/2026
DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
04/05/2026
MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with [...]
NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU
04/05/2026
PARIS et CAMBRIDGE, Mass., 04 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
04/05/2026
First quarter revenue growth of 1.6% First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10 First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Inspire Medical [...]
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
04/05/2026
Live webcast on Friday, May 8, 2026, beginning at 12:30 PM ET Event will feature Phase 1 clinical data for BGE-102 and the therapeutic rationale for development in atherosclerotic cardiovascular disease (ASCVD) and [...]
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
04/05/2026
MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer [...]
JellyFit Claims Evaluated: The Truth About Jelly Lean Fit Weight Loss Drops' 8 Ingredients Stacked with Gelatin Trick Recipe Hack Exposed
04/05/2026
JellyFit's 8-Ingredient Liquid Weight Loss Drops: Apple Cider Vinegar, Apple Pectin, Beet Root, and the Gelatin Trick Formula Explained for 2026 Largo, FL, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on May 1, 2026, the Compensation Committee [...]
InspireMD Reports First Quarter 2026 Financial Results
04/05/2026
- Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard neuro protection system for [...]
CooperCompanies Appoints Paul Keel to its Board of Directors
04/05/2026
SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director [...]
Janell Rae Releases Debut Book Satori: Awakening to Your Truest Self Through Energy Intelligence
05/05/2026
After 25 years of transformative client work, Janell Rae brings her complete Energy Intelligence Method™ to readers for the first time — offering a direct path back to the most authentic version of themselves. Silver [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 7 newly- [...]

Pages